INT74521

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.42
First Reported 1998
Last Reported 2008
Negated 0
Speculated 0
Reported most in Abstract
Documents 3
Total Number 3
Disease Relevance 2.78
Pain Relevance 1.13

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

mitochondrion (ERAL1) RNA binding (ERAL1) rRNA binding (ERAL1)
intracellular (ERAL1) ribosome biogenesis (ERAL1)
Anatomy Link Frequency
7E3 2
sacroiliac joint 1
ERAL1 (Homo sapiens)
Pain Link Frequency Relevance Heat
Arthritis 65 100.00 Very High Very High Very High
Inflammation 7 93.52 High High
Pain 4 92.52 High High
spinal inflammation 8 86.56 High High
Angina 6 68.80 Quite High
psoriasis 2 56.64 Quite High
backache 5 5.00 Very Low Very Low Very Low
visual analogue scale 4 5.00 Very Low Very Low Very Low
cINOD 3 5.00 Very Low Very Low Very Low
corticosteroid 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Arthritis 53 100.00 Very High Very High Very High
INFLAMMATION 6 93.52 High High
Pain 3 92.52 High High
Uveitis 4 87.84 High High
Low Back Pain 9 86.56 High High
Sacroiliitis 2 84.40 Quite High
Inflammatory Bowel Disease 1 83.68 Quite High
Juvenile Chronic Polyarthritis 14 83.32 Quite High
Syndrome 2 82.20 Quite High
Cv General 3 Under Development 6 68.80 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The era of platelet glycoprotein (GP) IIb/IIIa receptor inhibition in cardiology was inaugurated in 1994 with the publication of the Evaluation of 7E3 for the Prevention of Ischemic Complications (EPIC) trial results.
Negative_regulation (inhibition) of era in 7E3
1) Confidence 0.42 Published 1998 Journal Am. Heart J. Section Abstract Doc Link 9539495 Disease Relevance 0.32 Pain Relevance 0.07
The era of platelet glycoprotein (GP) IIb/IIIa receptor inhibition in cardiology was inaugurated in 1994 with the publication of the Evaluation of 7E3 for the Prevention of Ischemic Complications (EPIC) trial results.
Negative_regulation (inhibition) of era in 7E3
2) Confidence 0.42 Published 1998 Journal Eur. Heart J. Section Abstract Doc Link 9597518 Disease Relevance 0.32 Pain Relevance 0.07
ERA was defined according to the ILAR criteria [1]: onset of arthritis before the 16th birthday and persisting for at least 6 weeks; arthritis and enthesitis, or arthritis or enthesitis with at least 2 of (a) presence of or a history of sacroiliac joint tenderness and/or inflammatory lumbosacral pain, (b) presence of HLA-B27 antigen, (c) onset of arthritis in a male over 6 years of age, (d) acute (symptomatic) anterior uveitis (e) history of ankylosing spondylitis, enthesitis related arthritis, sacroiliitis with inflammatory bowel disease, Reiter's syndrome, or acute anterior uveitis in a first-degree relative [1].
Negative_regulation (persisting) of ERA in sacroiliac joint associated with spinal inflammation, pain, sacroiliitis, inflammation, syndrome, uveitis and arthritis
3) Confidence 0.04 Published 2008 Journal Pediatr Rheumatol Online J Section Body Doc Link PMC2577669 Disease Relevance 2.14 Pain Relevance 0.99

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox